184 related articles for article (PubMed ID: 8672510)
1. Iterative optimization of high-affinity protease inhibitors using phage display. 2. Plasma kallikrein and thrombin.
Markland W; Ley AC; Ladner RC
Biochemistry; 1996 Jun; 35(24):8058-67. PubMed ID: 8672510
[TBL] [Abstract][Full Text] [Related]
2. Iterative optimization of high-affinity proteases inhibitors using phage display. 1. Plasmin.
Markland W; Ley AC; Lee SW; Ladner RC
Biochemistry; 1996 Jun; 35(24):8045-57. PubMed ID: 8672509
[TBL] [Abstract][Full Text] [Related]
3. Obtaining a family of high-affinity, high-specificity protein inhibitors of plasmin and plasma kallikrein.
Ley AC; Markland W; Ladner RC
Mol Divers; 1996 Oct; 2(1-2):119-24. PubMed ID: 9238642
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective Kunitz domain inhibitors of plasma kallikrein designed by phage display.
Dennis MS; Herzka A; Lazarus RA
J Biol Chem; 1995 Oct; 270(43):25411-7. PubMed ID: 7592708
[TBL] [Abstract][Full Text] [Related]
5. Phage display selection of P1 mutants of BPTI directed against five different serine proteinases.
Kiczak L; Koscielska K; Otlewski J; Czerwinski M; Dadlez M
Biol Chem; 1999 Jan; 380(1):101-5. PubMed ID: 10064144
[TBL] [Abstract][Full Text] [Related]
6. Development of plasma kallikrein selective inhibitors.
Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
Katz BA; Liu B; Barnes M; Springman EB
Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
[TBL] [Abstract][Full Text] [Related]
8. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
[TBL] [Abstract][Full Text] [Related]
10. An evolutionarily conserved binding site for serine proteinase inhibitors in large conductance calcium-activated potassium channels.
Moss GW; Marshall J; Morabito M; Howe JR; Moczydlowski E
Biochemistry; 1996 Dec; 35(50):16024-35. PubMed ID: 8973172
[TBL] [Abstract][Full Text] [Related]
11. Engineering of a macromolecular scaffold to develop specific protease inhibitors.
Stoop AA; Craik CS
Nat Biotechnol; 2003 Sep; 21(9):1063-8. PubMed ID: 12923547
[TBL] [Abstract][Full Text] [Related]
12. Oxyanion-mediated inhibition of serine proteases.
Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
[TBL] [Abstract][Full Text] [Related]
13. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
[TBL] [Abstract][Full Text] [Related]
14. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies.
Lipovsek D; Lippow SM; Hackel BJ; Gregson MW; Cheng P; Kapila A; Wittrup KD
J Mol Biol; 2007 May; 368(4):1024-41. PubMed ID: 17382960
[TBL] [Abstract][Full Text] [Related]
15. Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies.
Sun J; Pons J; Craik CS
Biochemistry; 2003 Feb; 42(4):892-900. PubMed ID: 12549907
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of textilinin-1, a Kunitz-type serine protease inhibitor from the venom of the Australian common brown snake (Pseudonaja textilis).
Millers EK; Trabi M; Masci PP; Lavin MF; de Jersey J; Guddat LW
FEBS J; 2009 Jun; 276(11):3163-75. PubMed ID: 19490116
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibitors of the serine protease plasmin: probing the S3 and S3' subsites using a combinatorial library.
Xue F; Seto CT
J Med Chem; 2005 Nov; 48(22):6908-17. PubMed ID: 16250649
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of human tissue kallikrein variants.
Chan H; Springman EB; Clark JM
Protein Expr Purif; 1998 Apr; 12(3):361-70. PubMed ID: 9535704
[TBL] [Abstract][Full Text] [Related]
19. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
20. Purification and partial characterization of human neutrophil elastase inhibitors from the marine snail Cenchritis muricatus (Mollusca).
González Y; Tanaka AS; Hirata IY; del Rivero MA; Oliva ML; Araujo MS; Chávez MA
Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):506-13. PubMed ID: 16546427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]